<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00196183</url>
  </required_header>
  <id_info>
    <org_study_id>GE IDE No. C00504</org_study_id>
    <nct_id>NCT00196183</nct_id>
  </id_info>
  <brief_title>Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation</brief_title>
  <official_title>Randomized Study Comparing Pulmonary Vein Isolation Alone vs. Pulmonary Vein Isolation Plus Electrogram-Guided Substrate Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two strategies of catheter-based treatment of
      paroxysmal atrial fibrillation: Pulmonary vein isolation either alone or combined with
      electrogram-guided substrate-ablation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter ablation has evolved an accepted alternative in the curative treatment of atrial
      fibrillation (AF). However, discussion about the best ablation strategy is still ongoing.

      In patients with paroxysmal AF, it has been reproducibly demonstrated that curing rates of
      approximately 65-70% can be achieved with the electric isolation of pulmonary veins (PV)
      eliminating the initiating triggers of AF episodes. Recently, a new catheter ablation
      approach targeting in both atria fractionated, complex electrograms during ongoing AF and
      modifying thus the substrate maintaining AF has been described. The first describer of this
      technique reports curing rates of 92%. We want to compare in a randomized prospective study
      the treatment by PV isolation alone with a combined approach of PV isolation together with
      ablation of fractionated complex electrograms in patients with paroxysmal AF. Study endpoint
      is the achievement of stable sinus rhythm as assessed by 7 days holter ECG in the absence of
      antiarrhythmic drug treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">June 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sinus rhythm in follow-up in the absence of antiarrhythmic drugs after the first catheter ablation</measure>
    <time_frame>Sinus rhythm in follow-up in the absence of antiarrhythmic drugs after the first catheter ablation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>trigger-guided ablation of paroxysmal atrial fibrillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>trigger-+substrate guided ablation of paroxysmal atrial fibrillation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trigger-guided catheter-ablation</intervention_name>
    <description>trigger-guided ablation of paroxysmal atrial fibrillation</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trigger+substrate-guided catheter ablation</intervention_name>
    <description>trigger-+substrate guided ablation of paroxysmal atrial fibrillation</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 and &lt;80 years

          -  Symptomatic paroxysmal atrial fibrillation

          -  Drug-refractory

          -  Anticoagulation

        Exclusion Criteria:

          -  Hyperthyreosis

          -  Moderate-to-severe mitral valve valvulopathy

          -  LV-ejection fraction &lt;35%

          -  Prior ablation, PCI or heart surgery &lt;3 months

          -  Left atrial thrombus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claus Schmitt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Deutsches Herzzentrum Muenchen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabel Deisenhofer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum Muenchen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Muenchen</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Sch√∂mig A, Schmitt C. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation. 2005 Jun 7;111(22):2875-80. Epub 2005 May 31.</citation>
    <PMID>15927974</PMID>
  </reference>
  <reference>
    <citation>Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004 Jun 2;43(11):2044-53.</citation>
    <PMID>15172410</PMID>
  </reference>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>March 14, 2008</last_update_submitted>
  <last_update_submitted_qc>March 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

